iotaSciences, an Oxford, UK-based leader in single-cell biology handling solutions, raised an equity funding round of undisclosed amount.
Backers included Oxford Science Enterprises, and the Oxford Innovation EIS Growth Fund managed by Oxford Innovation Finance.
The company intends to use the funds for ongoing commercial activities in Europe, the U.S and Asia and further development of a next-generation single-cell cloning platform.
Founded in 2016 as a spin-out from the University of Oxford (UK) and led by Dr Michael Lutz, CEO, iotaSciences provides single-cell biology handling solutions, which are key to R&D workflows related Cell and Gene Therapy (CGT) and other applications.
FinSMEs
31/07/2024